About Spi Specialties Pharma Private Limited
Data last updated: 19 February 2026
Spi Specialties Pharma Private Limited is a private limited company based in Bengaluru, Karnataka, India, a subsidiary of Abf Overseas Limited. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 05 December 2013, the company has been in operation for over 13 years.
Registered with ROC Bangalore under CIN U24100KA2013PTC072350.
Capital: an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shrikant Bhaskar Pawar and Naseerulla Miyansaheb Khalilulla.
Last AGM: 03 September 2025. Financial statements filed for year ended 31 March 2025. Office: First Floor Regent Sunny Side 80Ft Road 8Th Block Koramangala, Bengaluru, Karnataka, India – 560030.
As per the financials filed for FY 2024, the company reported a revenue of ₹12.22 Cr, a decline of 2% compared to the previous year.
The company has a workforce of approximately 22 employees as per the latest available data. It operates as a subsidiary of Abf Overseas Limited.
The company is associated with 1 brand - Spi Pharma.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website spipharma.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressFirst Floor Regent Sunny Side 80Ft Road 8Th Block Koramangala, Bengaluru, Karnataka, India – 560030
-
IndustryPharma, Pharmaceutical Retailers & Distributors
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Spi Specialties Pharma Private Limited
Spi Specialties Pharma Private Limited operates one associated brand: SPI Pharma. These brands represent Spi Specialties Pharma Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Excipient products and formulations are manufactured for pharmaceutical uses. | spipharma.com |
Competitors & Alternatives of Spi Specialties Pharma Private Limited
Brands and companies operating in the same space as Spi Specialties Pharma Private Limited include Colorcon, DFE Pharma, Crest Cellulose and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Colorcon
|
Developer of specialty excipients and corporate-backed venture capital fund focused on healthcare startups | Harleysville, United States, United States | 1961 |
DFE Pharma
|
Developer and manufacturer of excipients for oral solid dosage forms and dry powder inhalations | Goch, Germany, Germany | 2011 |
Crest Cellulose
|
Pharmaceutical excipients and food ingredients are developed and manufactured. | Hyderabad, India, India | 2011 |
Scope Ingredients
|
Formulations, warehousing, and logistics services for pharmaceuticals are provided. | Chennai, India, India | 1959 |
Finar
|
Manufacturer of excipients, solvents, lab chemicals, food additives, and other fine chemicals | Ahmedabad, India, India | 1998 |
Pfanstiehl
|
APIs, injectable excipients, and bioprocessing solutions are manufactured. | Waukegan, United States, United States | 1919 |
Boai Nky Pharmaceuticals
|
Develops and manufactures pharmaceutical excipients, specializing in PVP products. | Jiaozuo, China, China | 1987 |
JRS Pharma
|
Supplies excipients, coatings, and technical services for health sciences worldwide. | Baden Baden, Germany, Germany | 1878 |
Meggle Pharma
|
Develops and manufactures pharmaceutical excipients for the industry. | Wasserburg Am Inn, Germany, Germany | 2005 |
Business Activity of Spi Specialties Pharma Private Limited
Spi Specialties Pharma Private Limited is engaged in the principal business activity of support service to organizations, with detailed activities including other support services to organizations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations | ********* |
Auditor Details of Spi Specialties Pharma Private Limited
Spi Specialties Pharma Private Limited is audited by S.R. Batliboi & Associates LLP for the financial year 2021. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S.R. Batliboi & Associates LLP | blur-value | blur-value | blur-value |
Board of Directors of Spi Specialties Pharma Private Limited
Spi Specialties Pharma Private Limited is currently managed by 2 directors, with 11 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shrikant Bhaskar Pawar | Whole-Time Director | 11 Mar 2025 | 1 Years 3 Months | Current |
| Naseerulla Miyansaheb Khalilulla | Whole-Time Director | 07 Jul 2025 | 1 Years 0 Months | Current |
Financials of Spi Specialties Pharma Private Limited FY 2025 filings available
Spi Specialties Pharma Private Limited reported revenue of ₹12.22 Cr (down 2% YoY) for FY 2024. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Spi Specialties Pharma Private Limited
As of FY 2021, Spi Specialties Pharma Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings Spi Specialties Pharma Private Limited
Spi Specialties Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Spi Specialties Pharma Private Limited
Spi Specialties Pharma Private Limited has a workforce of 22 employees as of Apr 05, 2024.
Employee Count & EPFO Data of Spi Specialties Pharma Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Spi Specialties Pharma Private Limited
GSTIN & GST Filing Data of Spi Specialties Pharma Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Spi Specialties Pharma Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Spi Specialties Pharma Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Spi Specialties Pharma Private Limited
MSME Payment Delays by Spi Specialties Pharma Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Spi Specialties Pharma Private Limited
Subsidiaries & Group Companies of Spi Specialties Pharma Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Spi Specialties Pharma Private Limited with ownership details.
MCA Filings & Documents of Spi Specialties Pharma Private Limited
MCA Filings & Documents of Spi Specialties Pharma Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Spi Specialties Pharma Private Limited
Frequently Asked Questions about Spi Specialties Pharma Private Limited
Spi Specialties Pharma Private Limited is an active private limited company in the pharma sector based in Bengaluru, Karnataka, India. It was incorporated on 05 December 2013 (13+ years old) and is registered under CIN U24100KA2013PTC072350. The company has 22 employees.
Spi Specialties Pharma Private Limited reported revenue of ₹12.22 Cr for FY 2024 (down 2.00% YoY).
The current directors of Spi Specialties Pharma Private Limited are:
The primary industry of Spi Specialties Pharma Private Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.
Spi Specialties Pharma Private Limited can be reached at the registered office: First Floor Regent Sunny Side 80Ft Road 8Th Block Koramangala, Bengaluru, Karnataka, India – 560030, or through the website spipharma.com.
The authorised capital is ₹1 Lakh, and the paid-up capital is ₹1 Lakh.